Signal from the log
GPN Vaccines
10 M$ · Australie, États-Unis · Biotech
GPN Vaccines, entre New York et Adélaïde, développe Gamma-PN, un vaccin contre le pneumocoque conçu pour protéger contre toutes ses souches et non contre une liste de sérotypes. Elle annonce un placement privé de 10 M$ sans nommer ses investisseurs.
Spotted
Announced on , logged by the watch of 2 November 2026.
- Operation
- Funding round
- Announced amount
- 10 M$
- Country
- Australie, États-Unis
- Sector
- Biotech
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
What is missing before publishing
- No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source prnewswire
Logged on 2 November 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.